Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Max Hoebink, et al, adding:
”Clinical Applicability of Anti-Xa Measurements to Monitor Unfractionated Heparin Activity During Arterial Procedures: A Scoping Review
This scoping review of 55 reports finds that while anti-Xa is a reliable reference test for heparin monitoring during arterial procedures, optimal target levels and their correlation with clinical outcomes remain poorly defined.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Tom Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 5, 2026, 08:27Morten Thaysen Andersen: Platelet Glycobiology and The Importance of FUT8 for Platelet Function
-
Jun 5, 2026, 08:10Michael Ertl: Air Pollution and Stroke – Which Patients Are Particularly at Risk?
-
Jun 5, 2026, 07:58Omid Seidizadeh: Pleasure to Present on VWD in Aging at the ERN-EuroBloodNet Webinar Series
-
Jun 5, 2026, 07:14Elissa Embrechts: A Small But Meaningful Step Towards Better Fall Risk Prediction in Stroke Rehabilitation
-
Jun 5, 2026, 03:27Lovish Garg: Restoring Venous Flow Through Catheter-Directed Thrombus Removal
-
Jun 5, 2026, 03:20Javed Anees: Anemia in Pregnancy Is Common, but Never Trivial
-
Jun 5, 2026, 02:52Andrada Seicean: Endoscopic Ultrasound and Portal Pressure Assessment in Patients Undergoing TIPS
-
Jun 5, 2026, 02:29Sam Tomy K: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis
-
Jun 5, 2026, 01:54Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?